Nadine Sommer
@sommern.bsky.social
PhD Student at the Rowett Institute• Investigating Lipodystrophy, Fatty Liver, Type II Diabetes & Field-Cycling MRI • 🏴🇩🇪
Reposted by Nadine Sommer
L is for Learning more and more about Lipodystrophy.
To mark #WorldLipodystrophyDay2025 we gathered some of the Rowett researchers involved in helping find a treatment for this rare and debilitating condition.
Here's to looking back this time next year at more great progress!
To mark #WorldLipodystrophyDay2025 we gathered some of the Rowett researchers involved in helping find a treatment for this rare and debilitating condition.
Here's to looking back this time next year at more great progress!
March 31, 2025 at 2:29 PM
L is for Learning more and more about Lipodystrophy.
To mark #WorldLipodystrophyDay2025 we gathered some of the Rowett researchers involved in helping find a treatment for this rare and debilitating condition.
Here's to looking back this time next year at more great progress!
To mark #WorldLipodystrophyDay2025 we gathered some of the Rowett researchers involved in helping find a treatment for this rare and debilitating condition.
Here's to looking back this time next year at more great progress!
Reposted by Nadine Sommer
Preclinical evaluation of tissue-selective gene therapies for congenital generalised lipodystrophy https://www.biorxiv.org/content/10.1101/2024.06.27.600757v1
Preclinical evaluation of tissue-selective gene therapies for congenital generalised lipodystrophy https://www.biorxiv.org/content/10.1101/2024.06.27.600757v1
Lipodystrophy is a rare disorder which can be life-threatening. Here individuals fail to develop or
www.biorxiv.org
June 28, 2024 at 3:20 AM
Preclinical evaluation of tissue-selective gene therapies for congenital generalised lipodystrophy https://www.biorxiv.org/content/10.1101/2024.06.27.600757v1